Nathan Vastesaeger

Summary

Affiliation: Merck Research Laboratories
Country: USA

Publications

  1. ncbi Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study
    Asta Baranauskaite
    Kaunas Medical University Hospital, Kaunas, Lithuania
    Ann Rheum Dis 71:541-8. 2012
  2. ncbi Predicting the outcome of ankylosing spondylitis therapy
    Nathan Vastesaeger
    Schering Plough Corporation, Kenilworth, New Jersey, USA
    Ann Rheum Dis 70:973-81. 2011

Detail Information

Publications2

  1. ncbi Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study
    Asta Baranauskaite
    Kaunas Medical University Hospital, Kaunas, Lithuania
    Ann Rheum Dis 71:541-8. 2012
    ..To compare the efficacy and safety of treatment with infliximab plus methotrexate with methotrexate alone in methotrexate-naive patients with active psoriatic arthritis (PsA)...
  2. ncbi Predicting the outcome of ankylosing spondylitis therapy
    Nathan Vastesaeger
    Schering Plough Corporation, Kenilworth, New Jersey, USA
    Ann Rheum Dis 70:973-81. 2011
    ....